1-20 of 21 results for subject:Screening
Librarians' tools
- Search time
- 0.268 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:Screening
- We searched for
- subject_t:Screening OR subject_ses:92923
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what stocks NHS England has of (a) covid-19 boosters, (b) covid-19 rapid tests, (c) N95 masks and (d) flu vaccines as of October 2023, in the context of preparations for winter 2023-24.
To ask the Secretary of State for Health and Social Care, what stocks NHS England has of (a) covid-19 boosters, (b) covid-19 rapid tests, (c) N95 masks and (d) flu vaccines as of October 2023, in the context of preparations for winter 2023-24.
COVID-19 vaccines are purchased by the UK Health Security Agency (UKHSA). NHS England manages the distribution of stock to the front-line. At the beginning of the autumn/winter campaign, NHS England had access to 14.5 million doses of applicable vaccines, to meet the needs of the eligible cohorts as advised by the Joint Committee on Vaccination and Immunisation. NHS England also has stocks of 1,509,200 COVID-19 rapid tests and 114,061,080 FFP3 respirators.
NHS England does not centrally procure or stock any adult flu vaccines. General practitioners and other providers are responsible for ordering adult flu vaccine directly from suppliers, which are used to deliver the national flu programme to the other eligible groups.
Children’s flu vaccines are centrally procured and distributed by UKHSA. We are unable to provide specific stack levels as this information is commercially sensitive but there are adequate stocks of the live attenuated vaccine.
To ask the Secretary of State for Health and Social Care, how many covid-19 PCR tests the NHS has sent to patients in the E17 postcode area as part of the programme to identify positive cases among people at highest risk from covid-19.
To ask the Secretary of State for Health and Social Care, how many covid-19 PCR tests the NHS has sent to patients in the E17 postcode area as part of the programme to identify positive cases among people at highest risk from covid-19.
As of 8 March 2022, 1,970 people in the E17 postcode were identified as at highest risk from COVID-19, based on the COVID-19 Treatment Methodology. As of 17 March, 2,315 priority polymerase chain reaction test kits have been sent to patients who may be suitable for COVID-19 treatments in this postcode. This includes replenishment kits sent automatically or ordered by the patient via 119. These figures have been rounded to the nearest five in accordance with disclosure rules.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 January 2021 to Question 96883 on Coronavirus: Screening, what comprehensive service descriptions are used in relation to Deloitte's contract for covid-19 testing; and pursuant to the Answer of 18 November 2020 to Question...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 January 2021 to Question 96883 on Coronavirus: Screening, what comprehensive service descriptions are used in relation to Deloitte's contract for covid-19 testing; and pursuant to the Answer of 18 November 2020 to Question...
The contract, containing the service descriptions, is available at the following link:
These include increasing our capacity to deliver the programme, supporting the national testing, meeting our end to end supply needs and determining our logistics.
Overall performance is monitored via a robust fortnightly cycle of contract management and performance reporting against agreed milestones. This includes review and approvals for each workstream, with additional governance aligned to Government standards and best practice.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89688 on Coronavirus: Screening, what the performance standards are that Deloitte is expected to meet under the terms of its contract relating to its involvement in the provision of...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89688 on Coronavirus: Screening, what the performance standards are that Deloitte is expected to meet under the terms of its contract relating to its involvement in the provision of...
All arrangements for Deloitte’s support to Test and Trace are subject to Crown Commercial Services terms. Each workstream has a comprehensive service description and is subject to regular performance monitoring and management to ensure they are delivering in line with the programme’s objectives.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89690 on Coronavirus: Screening, what the performance standards are that Lighthouse Labs is expected to meet under the terms of its contract relating to its involvement in the provision...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89690 on Coronavirus: Screening, what the performance standards are that Lighthouse Labs is expected to meet under the terms of its contract relating to its involvement in the provision...
All our contracts with Lighthouse Laboratories are constantly monitored against set criteria to ensure that the supplier is meeting expectations. We are unable to provide specific details of these contracts as they are commercially sensitive.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89689 on Coronavirus: Screening, what the performance standards are that Randox is expected to meet under the terms of its contract for covid-19 testing.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89689 on Coronavirus: Screening, what the performance standards are that Randox is expected to meet under the terms of its contract for covid-19 testing.
Performance and quality assurance standards and processes are included in the Government contracts with Randox. These are constantly monitored against to ensure that the supplier is meeting expectations. Due to the commercially sensitive nature of these agreements, the Department cannot provide specific details.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89687 on Coronavirus: Screening, what the performance standards are that Serco are expected to meet under the terms of its contract relating to its involvement in the provision of...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2020 to Question 89687 on Coronavirus: Screening, what the performance standards are that Serco are expected to meet under the terms of its contract relating to its involvement in the provision of...
Performance and quality assurance standards and processes are included in the Government contracts with Serco. These are commercially sensitive. The contracts have break clauses in them, meaning if the company does not meet required service levels, the contract may be cancelled and money reclaimed.
To ask the Secretary of State for Health and Social Care, how many (a) covid-19 test QR codes have been scanned at covid-19 test centres and (b) test results have been issued per day since August 1 2020.
To ask the Secretary of State for Health and Social Care, how many (a) covid-19 test QR codes have been scanned at covid-19 test centres and (b) test results have been issued per day since August 1 2020.
We do not publish data in the format requested.
To ask the Secretary of State for Health and Social Care, what the cap since 13 September 2020 has been on the number of tests that can be done at (a) drive in test centres and (b) walk through test centres; and who is responsible for setting that cap.
To ask the Secretary of State for Health and Social Care, what the cap since 13 September 2020 has been on the number of tests that can be done at (a) drive in test centres and (b) walk through test centres; and who is responsible for setting that cap.
The cap for the number of tests available at drive through sites is set on a daily basis and therefore the number of tests available on any given day does vary.
We are expanding capacity continually, having already surpassed our testing capacity target of 500,000 tests a day by the end of October.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2020 to Question 48980 on Deloitte: Coronavirus, whether his office was involved in the negotiation of the contract with Deloitte to perform covid-19 testing.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2020 to Question 48980 on Deloitte: Coronavirus, whether his office was involved in the negotiation of the contract with Deloitte to perform covid-19 testing.
The process of contract negotiation is not a process that routinely involves the Secretary of State or his office directly. Officials working on his behalf will act on his authority to negotiate a contract that best meets the needs of the service being proposed.
A summary of Deloitte's contract with the Department will be published in due course.
To ask the Secretary of State for Health and Social Care, how many tests have been taken at each covid-19 testing centre in London on each day since 31 August 2020.
To ask the Secretary of State for Health and Social Care, how many tests have been taken at each covid-19 testing centre in London on each day since 31 August 2020.
The Government does not publish data in the format requested.
To ask the Secretary of State for Health and Social Care, with reference to the contract with Randox for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance of...
To ask the Secretary of State for Health and Social Care, with reference to the contract with Randox for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance of...
The contract with Randox relates to the performance of laboratory testing following receipt of test samples. It does not relate to the public being able to secure a test.
Contractual penalties are generally unenforceable under English law and are therefore not included in this contract.
To ask the Secretary of State for Health and Social Care, with reference to the contract with Deloitte for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance of...
To ask the Secretary of State for Health and Social Care, with reference to the contract with Deloitte for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance of...
The contract with Deloitte does not include managing access to COVID-19 testing.
To ask the Secretary of State for Health and Social Care, with reference to the contract with Serco for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance of...
To ask the Secretary of State for Health and Social Care, with reference to the contract with Serco for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance of...
Serco is contracted to operate a proportion of the test locations. It is not responsible for the scheduling of access to COVID-19 tests.
Contractual penalties are generally unenforceable under English law and are therefore not included in this contract.
To ask the Secretary of State for Health and Social Care, with reference to the contract with Lighthouse Labs for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance...
To ask the Secretary of State for Health and Social Care, with reference to the contract with Lighthouse Labs for managing access to covid-19 testing, what penalties can be imposed under that contract in the event that people cannot secure a test; and who is responsible for monitoring the performance...
The contract with the Lighthouse Labs relates to the performance of laboratory testing following receipt of test samples. It does not relate to the public being able to secure a test.
Contractual penalties are generally unenforceable under English law and are therefore not included in this contract.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2020 to Question 48980 on Deloitte, if he will set out the total sum of monies paid by his Department to Deloitte for each month of 2020.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2020 to Question 48980 on Deloitte, if he will set out the total sum of monies paid by his Department to Deloitte for each month of 2020.
We do not currently hold data in the requested format. However, information on Deloitte's contract with the Department will be published in due course at the following link:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2020 to Question 48980 on Deloitte: Coronavirus, to whom Deloitte is required to report positive cases of covid-19; and within what timeframe those positive cases are required to be so reported.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2020 to Question 48980 on Deloitte: Coronavirus, to whom Deloitte is required to report positive cases of covid-19; and within what timeframe those positive cases are required to be so reported.
Deloitte is contracted to provide professional services support to the Department and the National Testing Programme. Deloitte’s role has included setting up testing facilities; coordinating the set-up of home and satellite delivery channels; and designing the digital platform that enables people to book a test and register their kit. Deloitte makes this digital information available to the National Pathology Exchange.
Once results are generated in the labs, the results information also flows to the National Pathology Exchange where the result is matched to the individual’s demographic information. These results are passed to Public Health England every 30 minutes through a data flow. As such, Deloitte does not have a role in the generation of results or the handling of positive case data.
To ask the Secretary of State for Health and Social Care, whether his Department's contract with Randox Laboratories requires the notification to Public Health England of positive covid-19 tests in line with the Health Protection (Notification) Regulations 2010; and how many positive covid-19 tests were notified by that company under...
To ask the Secretary of State for Health and Social Care, whether his Department's contract with Randox Laboratories requires the notification to Public Health England of positive covid-19 tests in line with the Health Protection (Notification) Regulations 2010; and how many positive covid-19 tests were notified by that company under...
COVID-19 is a notifiable disease. As such, under the Health Protection (Notification) Regulations 2010, all laboratories are legally required to notify positive incidences to Public Health England.
To ask the Secretary of State for Health and Social Care, what guidance his Department has issued on covid-19 testing for people who have relatives in care homes; and when people will be able to visit those homes.
To ask the Secretary of State for Health and Social Care, what guidance his Department has issued on covid-19 testing for people who have relatives in care homes; and when people will be able to visit those homes.
Anyone with suspected COVID-19 symptoms can access testing by using the self-referral portal. More information is available at the following link:
https://www.gov.uk/coronavirus
While we have recommended that care homes limit non-essential visits, we are clear that visits at the end of life are important both for the individual and their loved ones and should continue with appropriate infection control precautions.
We are aware that limiting visits in care homes is difficult for many families and residents who want to see their loved ones.
We are reviewing our policy on visitors and are looking to update our guidance shortly and continuing to explore how we support the sector.
To ask the Secretary of State for Health and Social Care, whether the contract with Deloitte for covid-19 testing requires that company to report positive cases to Public Health England and to local authorities.
To ask the Secretary of State for Health and Social Care, whether the contract with Deloitte for covid-19 testing requires that company to report positive cases to Public Health England and to local authorities.
As an existing professional services provider to the public sector, Deloitte’s expertise is being used to supplement in-house resource to deliver significant programmes of work, which currently includes the national response to COVID-19. The contract with Deloitte does not require the company to report positive cases to Public Health England and local authorities.